CAS 202983-32-2

1,3,5-Naphthalenetrisulfonicacid,8,8'-[carbonylbis(imino-4,1-phenylenecarbonylimino-4,1-phenylenecarbonylimino)]bis-,sodium salt (1:6)

Description:

1,3,5-Naphthalenetrisulfonic acid, 8,8'-[carbonylbis(imino-4,1-phenylenecarbonylimino-4,1-phenylenecarbonylimino)]bis-, sodium salt (1:6) is a complex organic compound characterized by its sulfonic acid groups and imino linkages. This compound features a naphthalene backbone, which contributes to its aromatic properties, and multiple sulfonic acid groups that enhance its solubility in water and potential for ion exchange. The presence of sodium ions indicates that it is a salt, which typically enhances its stability and solubility in aqueous solutions. The imino groups suggest potential reactivity and the ability to form coordination complexes, making it of interest in various chemical applications, including dye chemistry and as a potential reagent in organic synthesis. Its structural complexity may also impart unique optical properties, making it suitable for use in advanced materials or as a dye. Overall, this compound's characteristics make it a valuable substance in both industrial and research settings.

Formula: C₄₉H₃₆N₆O₂₃S₆・6Na

Synonyms:

• 1,3,5-Naphthalenetrisulfonicacid,8,8'-[carbonylbis(imino-4,1-phenylenecarbonylimino-4,1-phenylenecarbonylimino)]bis-,hexasodium salt (9CI)
• Nf 279

NF279

CAS: 202983-32-2

P2X1 antagonist

Formula: C₄₉H₃₆N₆Na₆O₂₃S₆

Purity: 98%

Color and Shape: Solid

Molecular weight: 1407.17

Ref: TM-TP2274

NF 279

CAS: 202983-32-2

Applications NF 279 is a potent and selective P2X1 antagonist.
References Kassack, M., et al.: Eur. J. Med. Chem., 39, 345 (2004); Damer, S., et al.: Eur. J. Pharm., 350, R5 (1998); Rettinger, J., et al.: Neuropharm., 39, 2044 (2000)

Formula: C₄₉H₃₀N₆O₂₃S₆·6Na

Color and Shape: Neat

Molecular weight: 1401.12

Ref: TR-N391680

NF279

CAS: 202983-32-2

NF279 is a low-potency, orally active, small molecule that was designed to act as a potent and selective antagonist of the P2Y receptor. It binds to the p2y receptor and blocks its activity. NF279 has demonstrated efficacy against autoimmune diseases in animal models, and it is being studied as a potential treatment for HIV infection. In addition, NF279 has been shown to reduce the release of glutamate in primary cells, which may contribute to its ability to treat anxiety disorders. NF279 also blocks detrusor muscle contractions and reduces intracellular Ca2+ levels in bladder cells isolated from rats with overactive bladders.

Formula: C₄₉H₃₀N₆O₂₃S₆·6Na

Purity: Min. 95%

Molecular weight: 1,401.12 g/mol

Ref: 3D-CIA98332